Whether you're a health system in need of a way to care for patients at home or a biopharma company searching for a solution to keep your trials going, physIQ's clinical-grade platform and FDA-cleared analytics are ready to scale to support patients and clinicians during this crisis.
Gary Conkright, physIQ's CEO, was interviewed by Mark Carman from WGN Radio 720 about the current COVID-19 crisis and how technology like physIQ's can help, similar to how it helped the Ebola crisis back in 2015.
At physIQ, we welcome the opportunity to speak with potential customers, partners or anyone with an interest in learning more about the transformative potential of our technology.
Contact Us